David L. Stark

Stem Cell Therapy International, Inc. is a surgical procedure that has been used successfully for 70+ years as a treatment of many diseases for which modern medicine has had no therapy, or in which 'state-of-art' therapies stopped being effective. A documented 5 millions of patients have been so treated worldwide to-date, evidenced by over 120,000 publications in MEDLINE amongst others. SCT is approved for use by the German authorities and the EU.

National Institute of Clinical Research provides medical services. It offers pre-dialysis and dialysis research services. The company was founded by Sali Aswad and is headquartered in Pasadena, CA.

AmStem Corp. researches and develops stem cell transplantation therapy and regenerative medicine. The company owns cord blood stem cell bank in Korea. The company was founded on December 28, 1992 and is headquartered in San Francisco, CA.

Parallax Diagnostics, Inc. provides diagnostic testing systems and solutions. It develops bio-medical products, diagnostic and monitoring platforms in the area of infectious diseases. The company was founded on April 12, 2010 and is headquartered in Cambridge, MA.

Parallax Health Sciences, Inc. was an integrated digital healthcare company. It was engaged in the provision of personalized patient care through remote healthcare services, behavioral health systems, and Point-of-Care diagnostic testing. The firm operated through the following segments: Remote Patient Monitoring, Behavioral Health Systems, and Corporate. The Remote Patient Monitoring segment offered a technology platform that includes a complete remote patient care delivery system through PHM. The Behavioral Health Systems segment included the intellectual property, Reliable Evidence-Based Outcomes Optimization Technologies, through its wholly-owned subsidiary, Parallax Behavioral Health, Inc. The Corporate segment consisted of management and administrative services. The company was founded on July 6, 2005 and was headquartered in Los Angeles, CA.